Chronic
inflammation is a characteristic feature of aging, and the relationship between cellular senescence and
inflammation, although extensively studied, is not well understood. An overlapping pathway screen identified human
polynucleotide phosphorylase (hPNPase(old-35)), an evolutionary conserved 3',5'-exoribonuclease, as a gene up-regulated during both terminal differentiation and cellular senescence. Enhanced expression of hPNPase(old-35) via a replication-incompetent adenovirus (Ad.hPNPase(old-35)) in human
melanoma cells and normal human melanocytes results in a characteristic senescence-like phenotype.
Reactive oxygen species (ROS) play a key role in the induction of both in vitro and in vivo senescence. We now document that overexpression of hPNPase(old-35) results in increased production of ROS, leading to activation of the nuclear factor (
NF)-kappaB pathway. Ad.hPNPase(old-35)
infection promotes degradation of
IkappaBalpha and nuclear translocation of
NF-kappaB and markedly increases binding of the transcriptional activator p50/p65. The generation of ROS and activation of
NF-kappaB by hPNPase(old-35) are prevented by treatment with a cell-permeable
antioxidant,
N-acetyl-l-cysteine.
Infection with Ad.hPNPase(old-35) enhances the production of
interleukin (IL)-6 and
IL-8, two classical
NF-kappaB-responsive
cytokines, and this induction is inhibited by
N-acetyl-l-cysteine. A
cytokine array reveals that Ad.hPNPase(old-35)
infection specifically induces the expression of proinflammatory
cytokines, such as
IL-6,
IL-8,
RANTES, and
matrix metalloproteinase (MMP)-3. We hypothesize that hPNPase(old-35) might play a significant role in producing pathological changes associated with aging by generating proinflammatory
cytokines via ROS and
NF-kappaB. Understanding the relationship between hPNPase(old-35) and
inflammation and aging provides a unique opportunity to mechanistically comprehend and potentially intervene in these physiologically important processes.